ArticleInternational journal of molecular sciences2019

Kinase-Inactivated EGFR Is Required for the Survival of Wild-Type EGFR-Expressing Cancer Cells Treated with Tyrosine Kinase Inhibitors.

Rintu Thomas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.